CRISPR Therapeutics AG (CRSP)

56.71 +0.25 (+0.44%) USD  |  NASDAQ  |  Dec 24, 16:00
More

CRISPR Therapeutics Proceeds from Stock Option Exercised (Quarterly)

Proceeds from Stock Option Exercised (Quarterly) Chart

View Proceeds from Stock Option Exercised (Quarterly) for CRSP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Proceeds from Stock Option Exercised (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Proceeds from Stock Option Exercised (Quarterly) Range, Past 5 Years

View Proceeds from Stock Option Exercised (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Proceeds from Stock Option Exercised (Quarterly) Benchmarks

View Proceeds from Stock Option Exercised (Quarterly) Benchmarks
Start Trial
Vertex Pharmaceuticals, Inc. Upgrade
Intellia Therapeutics, Inc. Upgrade
Novartis AG Upgrade
Beam Therapeutics, Inc. Upgrade
BeOne Medicines Ltd. Upgrade